Remove sponsors ibm
article thumbnail

Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards

HIT Consultant

Best in KLAS: Inpatient Clinical Care 340B Management Systems PharmaForce 340B Acute Care EMR: Large ( >400 Beds) Epic EpicCare Inpatient EMR Acute Care EMR: Midsize (151–400 Beds) Epic EpicCare Inpatient EMR Acute Care EMR: Small (1–150 Beds) MEDITECH Expanse Acute Care EMR Automated Dispensing Cabinets BD Pyxis MedStation ES Clinical Communications: (..)

article thumbnail

Forbes 30 Under 30 Winner Builds New Agency Management Software — Then Makes It Free 

Home Health Care

Over the next several years, they acquired funding from major venture capital firms; built a team that included alumni from companies like IBM, Home Care Pulse and SYNERGY HomeCare; and acquired home care software startup Rappora, which became part of the foundation for the current Careswitch platform. This article is sponsored by Careswitch.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine

HIT Consultant

As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around the responsible use of AI have moved to the forefront of debates among healthcare stakeholders – patients, providers, regulatory authorities, payors and sponsors.

article thumbnail

Isn’t It Eyeconic? Vision Care in the Evolving Health Care Ecosystem

Health Populi

IBM is building a Health Utility Network which includes Aetna and Anthem, among other partners, to use for credentialing, claims processing, and other services. Dr. John Whyte, Chief Medical Officer with WebMD, spoke about how people use the internet for health care search.

Doctors 98
article thumbnail

July 2022 Semi-Annual Health IT Market Review

HIT Consultant

IBM sells Watson Health assets to investment firm Francisco Partners. Walgreens aims to revolutionize the antiquated clinical trials model with an eye toward using its community reach to increase patient enrollment as well as racial and ethnic diversity in sponsor-led drug development research, executives said.